Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Fluphenazine for Psoriasis
NCT00929578Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluphenazine in psoriasis, sponsored by Tufts Medical Center. Started Nov 2008; status: completed.
02
Drugs
fluphenazine
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00929578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929578.